Overview of current toxicological knowledge of engineered nanoparticles

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 6 SUPPL., 2011, Pages

  Castranova, Vincent ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; MULTI WALLED NANOTUBE; NANOPARTICLE; SINGLE WALLED NANOTUBE; TITANIUM DIOXIDE;

LUNG INJURY; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PNEUMONIA; REVIEW;

ANIMALIA;

EID: 79959236252     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31821b1e5a     Document Type: Article

References (36)

1. Roco MC. Science and technology integration for increased human potential and societal outcomes. Ann NY Acad Sci. 2004;1013:1-6.
2. Lux Research. The Nanotech Report. 5th ed. New York, NY: Lux Research; 2007.
3. Maynard AD, Kuempel E. Airborne nanostructured particles and occupational health. J Nanoparticle Res. 2005;7:587-614. (Pubitemid 41767360)
4. Sager TM, Kommineni C, Castranova V. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Particle Fibre Toxicol. 2008;5:17.
5. Shvedova AA, Sager T, Murray A, et al. Critical issues in the evaluation of possible effects resulting from airborne nanoparticles. In:Monteiro-Riviere N and Tran L, eds. Nanotechnology: Characterization, Dosing and Health Effects. Philadelphia, PA: Informa Healthcare; 2007;221-232.
6. Mercer RR, Scabilloni J, Wang L, et al. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single walled carbon nanotubes in a mouse model. Am J Physiol: Lung Cell Mol Physiol. 2008;294: L87-L97. (Pubitemid 351380321)
7. Porter DW, Holian A, Sriram K, et al. Engineered titanium dioxide nanowires toxicity in vitro and in vivo. The Toxicologist. 2008;102:A1492.
8. Shvedova AA, Kisin ER, Mercer R, et al. Unusual inflammatory and fibrogenic pulmonary responses to singlewalled carbon nanotubes inmice. Am J Physiol: Lung Cell Mol Physiol. 2005;289:L698-L708. (Pubitemid 41504399)
9. Pacurari M, Castranova V, Vallyathan V. Single- and multi-walled carbon nanotubes vs asbestos: are the carbon nanotubes a new health risk to humans? J Toxicol Environ Health. Part A. 2010;73:378-395.
10. Nel A, Xia T, Madler L, Li N. Toxic potential of nanomaterials at the nanolevel. Science. 2006;311:622-627.
11. Rushton EK, Jiang J, Leonard SS, et al. Concepts of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response-metrics. J Toxicol Environ Health. Part A. 2010;73:445-461.
12. Shvedova AA, Kisin ER, Murray AR, et al. Exposure to carbon nanotube material: assessment of the biological effects of nanotube materials using human keratinocytes. J Toxicol Environ Health. Part A. 2003;66:1901-1926.
13. Shvedova AA, Kisin E, Murray AR, et al. Inhalation versus aspiration of single walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidant stress and mutagenesis. Am J Physiol: Lung Cell Mol Physiol. 2008;295:L552-L565.
14. Nel A, Madler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nature Materials. 2009;8:543-557.
15. Sayes CM, Fortner JD, Guo W, et al. The differential cytotoxicity of water-soluble fullerenes. Nano Letters. 2004;4:1881-1887.
16. Sayes CM, Marchione AA, Reed KL, Warheit DB. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Letters. 2007;7:2399-2406. (Pubitemid 47310138)
17. Bernstein D, Castranova V, Donaldson K, et al. Testing of fibrous particles: short-term assays and strategies report of an ILSI Risk Science Institute working group. Inhal Toxicol. 2005;17:497-537. (Pubitemid 41166565)
18. Roberts JR, Young S-H, Castranova V, Antonini JM. Soluble metals in residual oil fly ash alter innate and adaptive pulmonary immune responses to bacterial infection in rats. Toxicol Appl Pharmacol. 2007;221:306-319. (Pubitemid 46860313)
19. Sager TM, Molina R, Donaghey T, Brain J, Castranova V. Effects of particle size and route of exposure on the bioavailability of zinc from nano-sized zinc oxide particles. The Toxicologist. 2010;114:A278.
20. George S, Pokhrel S, Xia T, et al. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano. 2010;4:15-29.
21. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single walled carbon nanotube material. J Toxicol Environ Health. Part A. 2004;67:87-107. (Pubitemid 38117533)
22. Johnson DR, Mathner MM, Kennedy AJ, Steevens JA. Potential for occupational exposure to engineered carbon-based nanomaterials in environmental laboratory studies. Environ Health Perspect. 2010;118:49-54.
23. Han JH, Lee EJ, Lee JH, et al. Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facility. Inhal Toxicol. 2008;20:741-749. (Pubitemid 351882937)
24. Methner MM. Effectiveness of local exhaust ventilation (LEV) in controlling engineered nanomaterial emissions during reactor cleanout operations. J Occup Environ Hyg. 2008;5:D63-D69.
25. Nurkiewicz TR, Porter DW, Hubbs AF, et al. Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Particle Fibre Toxicol. 2008;5:1.
26. LeBlanc AJ, Cumpston JL, Chen BT, Frazer D, Castranova V, Nurkiewicz TR. Nanoparticle inhalation impairs endothelium-dependent vasodilation in subepicardial arterioles. J Toxicol Environ Health. Part A. 2009;72:1576-1584.
27. Sriram K, Porter DW, Tsuruoka S, et al. Neuroinflammatory responses following exposure to engineered nanomaterials. The Toxicologist. 2007;96:A1390.
28. Porter DW, Hubbs A, Mercer R, et al. Mouse pulmonary dose- and time-course response induced by exposure to multi-walled carbon nanotubes. Toxicol. 2010;269:136-147.
29. Porter D, Wolfarth MG, Chen BT, et al. Pulmonary toxicity of inhaled multi-walled carbon nanotubes. The Toxicologist. 2009;108:A2193.
30. Sriram K, Porter DW, Jefferson AM, et al. Neuroinflammation and bloodbrain barrier changes following exposure to engineered nanomaterials. The Toxicologist. 2009;108:A2197.
31. Kreyling WG, Semmler M, Erbe F, et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent and low. J Toxicol Environ Health. Part A. 2002;65:1513-1530. (Pubitemid 35217498)
32. Nurkiewicz TR, Porter DM, Barger M, et al. Systemicmicrovascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ Health Perspect. 2006;114:412-419. (Pubitemid 43338267)
33. LeBlanc AL, Moseley AM, Chen BT, Frazer D, Castranova V, Nurkiewicz TR. Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen species-dependent mechanisms. Cardiovas Toxicol. 2010;10:27-36.
34. Knuckle TL, Frazer DG, Cumpston JL, Chen BT, Castranova V, Nurkiewicz TR. Nanoparticle inhalation modulates arteriolar sympathetic constriction: role nitric oxide, prostanoids, and α-adrenergic receptors. The Toxicologist. 2010;114:A1728.
35. Cruts B, van Etten L, Tornquist H, et al. Exposure to diesel exhaust induces changes in EEG in human volunteers. Particle Fibre Toxicol. 2008;5:4.
36. Barath S, Mills NL, Landbeck M, et al. Impaired vascular function after exposure to diesel exhaust generated at urban transient running conditions. Particle Fibre Toxicol. 2010:7:19.